summer intership training ppt
DESCRIPTION
TRANSCRIPT
![Page 1: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/1.jpg)
A STUDY ON RECENT TRENDS IN CARDIO-DIABETIC MANAGEMENT
Under the Guidance of:- Presented By :-
Mrs. Nidhi Verma Vishal Sharma
Faculty, PCTE MBA 2C
Ludhiana
![Page 2: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/2.jpg)
PHARMACEUTICAL INDUSTRY
Introduction
History Advantage to India Growth Scenario
![Page 3: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/3.jpg)
MOREPEN LABORATORIES LTD.
![Page 4: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/4.jpg)
VisionTo be a Global pharmaceutical player with strong
R&Dsupport and internationally accredited plants in
India for cost effective generic products.
Mission To Leverage these world-class resources for
partnership with large international players to jointly exploit the opportunities in the growing, regulated global generics market.
![Page 5: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/5.jpg)
HISTORICAL BACKGROUND OF
GROUP
![Page 6: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/6.jpg)
MANUFACTURING PLANTSLocation
Parwanoo Plant Baddi PlantMasulkhana
Plant
![Page 7: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/7.jpg)
INTRODUCTION ABOUT DIFFERENT DIVISION
Divisions
Medicus
Dr. Morepen
Medipath
![Page 8: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/8.jpg)
DETAILED OPERATIONS OF TRAINING UNIT
Working on Projects and Surveys.
Promotion of brands through Doctors.
Promotion of brands through Print media.
Enabling easy availability of drugs through strong distribution channel.
![Page 9: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/9.jpg)
IMPORTANT INFORMATION
Unit has network that extends to 250
distributors, 2500 top retailers.
It also caters to 9000 Hospitals, 7500 Clinical Laboratories & 1500 Blood Banks.
Largest Producer of Loratadine.
A strong links with 40,000 doctors.
![Page 10: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/10.jpg)
SWOT ANALYSIS OF MOREPEN LABORATORIES
Weakness1.Low brand image.2.Less presence in domestic market.
Opportunity1. To launch new products because of expiry of patents of some of molecules.
Threats1.A Strong competition from other marketing agencies.
SWOT Analysis of Morepen
Laboratories
![Page 11: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/11.jpg)
CARDIO-DIABETIC MANAGEMENT
Cardio-Diabetic Management
Cardiac diseasesDiabetes diseases
Double Jeopardy
![Page 12: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/12.jpg)
OBJECTIVES
To know causes of increasing cardio diabetic problems.
To check the treatment given by doctors in recent cardio-diabetic management.
To identify the factor associated with the promotion of cardio-diabetic management.
![Page 13: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/13.jpg)
NEED OF STUDY
A figure expected to increase to 1.5 billion by 2025 of Cardio-diabetic patients.
Pharmaceutical Company can also play a crucial role in cardiac-diabetic management.
To grab the market of cardiovascular and diabetic drugs.
A lot of expenditure is expected to be made by people in future.
To promote Cardio-diabetic management.
![Page 14: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/14.jpg)
RESEARCH METHODOLOGY
Scope of Study
Scope of research is mainly restricted to the Pharmaceutical Company and Doctors.
Research Design
It constitutes the blueprint for collection, measurement and analysis of data. This study follows the descriptive design.
Sampling
Universe
Doctors especially cardiologist, dibetologist and consulting physicians in the world.
![Page 15: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/15.jpg)
Population
Cardiologist, Dibetologist and Consulting physicians in the New Delhi.
Sampling technique
The selection of Doctors is done on the basis of Convenience Sampling.
Sampling unit
The sampling unit in this report is any cardiologist and dibetologist or consulting physicians in west zone of New Delhi.
Sample size
Sample size is 50.
![Page 16: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/16.jpg)
METHOD OF DATA COLLECTION
PRIMARY DATA
METHOD OF PRIMARY DATA COLLECTION
The method followed in obtaining the primary data was through the structured questionnaire.
SECONDARY DATA
METHOD OF SECONDARY DATA COLLECTION:
Journals and Magazines Internet
![Page 17: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/17.jpg)
GRAPH 4.1 Causes of increasing cardio-diabetic diseases at faster rate. (N=50)
![Page 18: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/18.jpg)
Graph 4.2 Current treatment regimen is sufficient for cardiac patient (N=50).
![Page 19: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/19.jpg)
Graph 4.3 Therapy preferred for cardiac patient. (N=50)
![Page 20: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/20.jpg)
Graph4.4 The combination or one preferred for cardiac patient.
![Page 21: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/21.jpg)
Graph 4.5 The molecule generally preferred by doctor for cardiac patients. (N=50)
![Page 22: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/22.jpg)
Graph 4.6 The brand generally preferred by doctor for their cardiac patient. (N=50)
![Page 23: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/23.jpg)
The brand preferred for cardiac patient (Contd…)
![Page 24: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/24.jpg)
Graph 4.7 The combination or one preferred for diabetic patient. (N=50)
![Page 25: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/25.jpg)
Graph 4.8 The molecules preferred for diabetic patients. (N=50)
![Page 26: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/26.jpg)
Graph 4.9 The brands preferred for diabetic patients. (N=50)
![Page 27: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/27.jpg)
Graph 4.10 Factors considered while referring the brand of medicine.(N=50)
![Page 28: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/28.jpg)
Graph 4.11 Pharma-Company can play crucial role in cardiac-diabetic management
![Page 29: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/29.jpg)
RESULTS AND FINDINGS Cause of increasing cardiac and diabetic disease is
Lack of awareness among patients and patient’s inadequate education.
Combination therapy is preferred most for Cardio-diabetic patient.
Doctors some time lack in knowledge of drugs . Practitioner also take care of combination drugs for
cardio-diabetic patients. Quality is the first preference of doctors while
referring the brand of medicines. Practitioners need consultancy of Pharma-Company
representators time to time.
![Page 30: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/30.jpg)
SUGGESTIONS
Pharma Company can play its role in cardio-diabetic management by Maintaining good quality and reasonable price.
Consulting practioners time to time.
Advertising regarding awareness.
Formation of new molecule through research.
Making the salt written by practioners in this study.
Formation of drugs taking care of combination drugs,differrent agents in a category,
![Page 31: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/31.jpg)
![Page 32: Summer Intership Training Ppt](https://reader033.vdocument.in/reader033/viewer/2022061301/54d9942c4a795989138b47ef/html5/thumbnails/32.jpg)
THANK YOU